This disclosure relates to biosensors and methods for forming biosensors. Particularly, this disclosure relates to micro-fluidic devices and methods for forming them.
Biosensors are devices for sensing and detecting biomolecules and operate on the basis of electronic, electrochemical, optical, and/or mechanical detection principles. Biosensors can sense charges, photons, and mechanical properties of bio-entities or biomolecules, or through molecular tags. The detection can be performed by detecting the bio-entities or biomolecules themselves, or through interaction and reaction between specified reactants and bio-entities/biomolecules. Biosensors continue to be miniaturized to reduce sample size while increasing sensitivity and information content.
A flow cell is a type of biosensor that includes micro-fluidic structures that allows external detection of its contents through a transparent window, for example, with microscopes, spectroscopes, or refractometers. The flow cell includes many capture sites on which biochemical reactions occur. The capture sites may be patterned or unpatterned (randomly distributed) on or in one or several microfluidic channels. Flow cells may be used to analyze biomolecules, conduct reactions, and irradiate samples. For example, flow cells may be used to for deoxyribonucleic acid (DNA) sequencing using fluorescent dyes for optical sensing.
Optical sensing techniques continue to improve, primarily from using better cameras with more pixels and better sensitivity to obtain more information from a flow cell. To benefit from the improved optical sensing techniques, the capture sites in flow cells are further miniaturized using semiconductor processing techniques. Challenges in fabrication of the flow cells using semiconductor processes arise, for example, due to compatibility issues between the semiconductor fabrication processes, the biological applications, and restrictions and/or limits on the semiconductor fabrication processes.
Aspects of the present disclosure are best understood from the following detailed description when read with the accompanying figures. It is emphasized that, in accordance with the standard practice in the industry, various features are not drawn to scale. In fact, the dimensions of the various features may be arbitrarily increased or reduced for clarity of discussion.
It is to be understood that the following disclosure provides many different embodiments, or examples, for implementing different features of the invention. Specific examples of components and arrangements are described below to simplify the present disclosure. These are, of course, merely examples and are not intended to be limiting. Moreover, the formation of a first feature over or on a second feature in the description that follows may include embodiments in which the first and second features are formed in direct contact, and may also include embodiments in which additional features may be formed interposing the first and second features, such that the first and second features may not be in direct contact. Further still, references to relative terms such as “top”, “front”, “bottom”, and “back” are used to provide a relative relationship between elements and are not intended to imply any absolute direction. Various features may be arbitrarily drawn in different scales for simplicity and clarity.
A flow cell involves various bioreceptors which react with various biological material of interest in one or more patterned capture sites. One such reaction is the polymerase chain reaction (PCR) that can multiply by orders of magnitude the number of molecular strands at a site. Various approaches are used to differentiate among different reactants and reactions for detection. One common approach is to tag a reaction with a fluorescent or phosphorescent label that emits a detectible photon that can be photographed externally. Different tags can be made to emit a different fluorescence, phosphorescence, or otherwise detectible and differentiable radiation. Nature of the detection would be determined based on the type of signal transduced. The signal transduced may be photons, for example, where a different wavelength of light is generated for different biological materials or reactions. In the example of deoxyribonucleic acid (DNA) sequencing, a different color may be emitted for a different DNA-base (i.e., A, G, C, and T).
The bioreceptors are located within various microfluidic channels that deliver biological material to the sensors. The microfluidic channels may be a part of a microfluidic system that includes pumps, valves, and various measurement devices such as flow meters, pressure transducers, and temperature sensors. Combinations of fluid processing and sensing may be advantageously integrated.
Semiconductor processing often involves baking, curing, and exposing various surfaces to plasma energy and radiation energy. At high temperatures (i.e., above about 100 degrees Celsius, or over 150 degree Celsius) and/or high energies, these processes would damage or destroy organic bioreceptors and capture sites, which usually are delicate bio-molecules or very thin layers of surface chemistry. According to various embodiments. the surface modification chemistry of capture sites includes an adhesive promoter layer, for example, hexamethyldisilazane (HMDS) or 3-aminopropyl triethoxysilane (APTES), and a bio-medium layer, for example agar, or hydrogel. In some embodiments, the adhesive promoter layer and the bio-medium layer may be mixed and applied to the surface together. The adhesive promoter, usually a form of silane, attaches to silicon-containing surfaces. The bio-medium layer attaches to the adhesive promoter. Without the adhesive promoter, a bio-medium may detach from a silicon-containing surface.
Thus, the bio-functionalization of surfaces on which bio-molecules are attached, are often performed after all the semiconductor processes are completed to avoid being exposed to the high temperature processes. In some designs, the microfluidic channels are formed directly on a substrate, usually a transparent substrate such as quartz, or an opaque substrate such as a silicon wafer, along with capture sites. At least one side of the flow cell is transparent to allow optical sensing of emitted radiation. By use of the term “transparent,” it is not intended that the disclosure be limited to substrates that are 100% light transmissive. Rather, transparent is used herein consistently with common usage by those in the field to indicate transmissivity sufficient to obtain the desired functionality of the resulting device.
In other designs, the microfluidic channels are formed on a microfluidic substrate that is subsequently bonded to another substrate having the capture sites. In the case where the microfluidic channel is in one of the substrates, the microfluidic channel formation, usually etching a trench or via into the substrate, can be difficult to manufacture on a transparent substrate. To avoid damage, when a high temperature bonding process is used, the temperature-sensitive materials are deposited on the interior walls of the microfluidic channels after the bonding process and the microfluidic channels are enclosed. A high concentration of material is flowed through each flow cell through the microfluidic channel surfaces having some affinity for the material. However, the density and thickness of material that attaches to the surfaces are hard to control, and the process is slow and wasteful of the temperature-sensitive material. In some cases, the material density varies throughout the flow cell or a batch of flow cells (not uniform) as the concentrations in the reagents change from inlet to outlet. The random, non-aligned locations and non-uniform concentrations complicate resolution of detectible activities at different sites using image processing algorithms. The locations may overlap each other and are hard to resolve. The randomness also makes it difficult to correlate between different flow cells because each would have different mapping of capture sites.
The various embodiments of the present disclosure contemplate a wafer-level process and a flow cell that addresses many of these issues by avoiding high temperature processing and/or allowing the use of dense patterns of capture sites without traditional photolithography on a transparent substrate. The bioreceptors, for example, DNA primers, are attached to the capture sites after the flow cell is fabricated. The site locations are patterned with an adhesive promoter layer and a bio-medium to form the capture sites. The density issue and the random, non-aligned location issue are addressed by forcing the bioreceptors to attach only at the patterned capture sites. The material selected for capture sites allows certain semiconductor processes to be used in fabricating the flow cell that otherwise cannot be used, for example, with processes that use a low temperature baking and curing. The various method embodiments of the present disclosure may be performed in a semiconductor fabrication facility. In more detail, the processing of materials on transparent substrates such as quartz and glass and etching of transparent substrates are often incompatible with some stages of the CMOS process because, for example, the glass processing can introduce particles that are considered contaminants for other CMOS processes. Some embodiments of the present disclosure involve no glass processing or minimal processing of glass when it is used as a transparent substrate.
In certain embodiments, the flow cell of the present disclosure is formed by combining two substrates, at least one of which is transparent.
The capture sites have certain chemistries that allow some material to bind to it. According to various embodiments, a bio-medium on which various bio-materials can bind, including agar or polyethylene glycol (PEG) hydrogel, is disposed on the capture sites. The bio-medium is connected to the capture site on the substrate through an adhesion promotion layer, which may be 3-aminopropyl triethoxysilane (APTES), or hexamethyldisilazane (HMDS).
A bonding polymer layer is disposed between the first substrate 101 and the transparent substrate 103. The bonding polymer layer 119 defines the microfluidic channels 111, 113, and 115 and seals the adjacent microfluidic channels from each other. The bonding polymer layer 119 adheres to both the first substrate 101 and the transparent substrate 103 and also seals the flow cell 100 along the perimeter such that the only access to the microfluidic channels 111, 113, and 115 is through the inlet/outlet 107/109.
In operation 202 of
At least two through-holes are formed for every flow cell—an inlet and an outlet. More than two through-holes may be used for different inlet fluids or if the flow cell performs separation of the analyte and more than one outlet is used. The through holes may be formed on separate substrates or the same substrate. Two through holes may be formed on the same substrate, either the first substrate or the second substrate.
In operations 204 to 208, a number of first capture sites is formed on a first substrate. In operation 204, a nanoimprint lithography (NIL) stamp stamps a patterned adhesive promoter on a first substrate. In an NIL process, a sample liquid, also called ink, is transferred to a planar target surface in a stamping motion. The stamp may be a silicone material such as polydimethylsiloxane (PDMS), a silicon material, or a silicon oxide material. The island features are formed by molding, photolithographic patterning, or ion beam patterning. Depending on the process used, the island features may be small with a small pitch. For example, the island features may be tens of angstroms across with a pitch in the same range. In some examples, each island may have a width and a length of about 10 to 50 angstroms. In other examples, each island may have a width and a length of about 50 to 200 angstroms. The island size is determined from the use of the flow cell. For DNA sequencing where smaller clusters are detectible by the optical sensing instruments, the island features may be about 20 angstroms. If the flow cell is used to work with cells or large biomolecules, larger islands may be used.
The island features contact the liquid sample in a reservoir, much like a stamp first contacts an ink well. Some liquid sample is retained on the island surface by the island feature. The stamp is then pressed onto a surface of the substrate to transfer at least a portion of the liquid sample from the island surface to the substrate surface.
The NIL stamp 305 makes contact with the first substrate 301 and is lifted as shown in
In operation 206 of
The NIL stamp 315 makes contact with the first substrate 301 and is lifted as shown in
Depending on the particular materials used for the adhesive promoter and for the bio-medium, the substrate may be baked at a relatively low temperature to covalently bond the bio-medium and the adhesive promoter. In some embodiments, the covalent bonds are formed at a temperature of 40 degrees Celsius to 200 degrees Celsius. In some embodiments, the materials are irradiated to promote the covalent bonding using UV/Vis/IR light for curing. A capture site includes an adhesive promoter layer and a bio-medium layer bonded over the adhesive promoter layer.
Referring back to
Referring back to
Referring back to
In operation 222, the first substrate and the second substrate are mounted. In some embodiments, a transparent substrate is mounted on a non-transparent substrate when the alignment sensor can use features on the non-transparent substrate detectible through the transparent substrate. After the substrates are mounted, in operation 224, the first substrate and the second substrate are baked at a temperature less than 100 degrees Celsius, with or without a downward pressure during the baking. In addition or instead of baking, an ultraviolet (UV) light may be applied to facilitate bonding of the polymer layer to a substrate. Once bonded, the patterned polymer layer forms a seal against the substrate bonded. The bonding operation may include one or many of baking, mechanical pressure application, and UV light. In certain embodiments, the UV light may be patterned so its application is directed toward the areas of the polymer layer and not directed toward capture sites. The photomask used for forming the patterned polymer layer may be used to pattern the UV light.
After the bonding operation, any backside tape or handling apparatus is removed from the bonded substrates. In one embodiment, an UV tape is applied to one of the substrates to facilitate handling. The UV light that bonds the substrate and the polymer layer can also degrade the adhesive on the tape to render it easily removable. After the bonding operation, the substrates may be diced or singulated to form individual flow cells as shown in
The present disclosure also pertains to alternate methods of forming capture sites on a substrate using an NIL process.
In operation 404 of
The punch features 509 surfaces may be treated to increase its hardness and to ensure that it does not bond during the stamping operation to the material on substrate 500. For example, an additional baking operation at about 200-460 degrees Celsius or UV curing may be used to harden punch features. The substrate 500 may be cleaned after the stamping operation to ensure that no silicon oxide material remains at the bottom of the openings 511. The NIL stamp 507 is inspected and replaced if necessary to ensure mechanical integrity during the stamping operation.
The NIL stamp 507 is lifted as shown in
Referring to
In operation 410, the substrate is soft baked to covalently bond the bio-medium and the patterned adhesive promoter. Operation 410 is the same as operation 208 of
The base substrate 553 includes a through hole 557, which may be formed after the soft bottom layer and optionally the coated top layer is deposited. Although only one through hole 557 is illustrated, embodiments are contemplated wherein two or more through holes are formed. A patterned polymer layer 559 is disposed between the first substrate and the second substrate and defines microfluidic channel walls. The polymer bonding process of operation 218 of
In some embodiments, capture sites are formed after the substrates are bonded. After the stamping operation 404 of
According to some embodiments, a flow cell may include recessed capture sites as shown in
In
In
According to various embodiments, the capture sites in a flow cell may have a relatively flat surface (
One aspect of the present disclosure pertains to a method of manufacturing a flow cell that includes forming stamping a patterned adhesive promoter on a first substrate using nanoimprint lithography, stamping a bio-medium on the patterned adhesive promoter on the first substrate using nanoimprint lithography to form a first capture site pattern, forming a patterned polymer layer on the first substrate or a second substrate, and polymer bonding the first substrate to the second substrate. The first substrate or the second substrate or both substrates are transparent. The method may also include soft baking the first substrate after stamping a bio-medium to covalently bond the bio-medium and the patterned adhesive promoter. In some embodiments, the method also includes stamping a patterned adhesive promoter on the second substrate using nanoimprint lithography and stamping a bio-medium on the patterned adhesive promoter on the second substrate using nanoimprint lithography to form a second capture site pattern. The first capture site pattern and the second capture site pattern may be aligned in a top view. In some embodiments, the method also includes laser drilling one or more through holes in the second substrate. The polymer bonding operation may include aligning the first substrate and the second substrate, mounting the first substrate and the second substrate, and baking the first substrate and the second substrate at a temperature less than 100 degrees Celsius.
Another aspect of the present disclosure pertains to a method of manufacturing a flow cell. The method includes providing a first substrate having a base substrate, a soft bottom layer on the base substrate, and a coated top layer, stamping a surface chemical pattern by stamping through the coated top layer and stop beneath an interface of the soft bottom layer and the coated top layer, exposing the first substrate to an adhesive promoter, exposing the first substrate to a bio-medium, forming a patterned polymer layer on the first substrate or a second substrate, and polymer bonding the first substrate to the second substrate. The adhesive promoter reacts and attaches only to the coated top layer and the bio-medium attaches to only the adhesive promoter. The first substrate or the second substrate or both substrates are transparent. In some embodiments, the coated top layer is a spin-on-glass (SOG) oxide. In some embodiments, the soft bottom layer is a thermal plastic resin.
The present disclosure also pertains to a flow cell having a transparent substrate and a bottom substrate, which may or may not be transparent. One of the substrates has through holes. The flow cell also includes a patterned photoresist dry film between the first substrate and the second substrate. The patterned polymer layers form microfluidic channel walls between the first substrate and the substrate. A plurality of patterned capture sites within microfluidic channels on the first substrate, the second substrate, or both. The plurality of capture sites each comprises a patterned adhesive promoter and a bio-medium. The patterned adhesive promoter and the bio-medium may be covalently bonded. The patterned capture sites may be disposed on a surface chemical pattern having silicon oxide islands each disposed on an outcrop of a soft bottom layer over a base substrate. The soft bottom layer may be aluminum, copper, titanium, an alloy of these, or a combination of these or a thermal plastic resin. The plurality of patterned capture sites may be recessed into the first substrate, the second substrate, or both, formed directly on a planar surface of the first substrate, the second substrate, or both. The first substrate and the second substrate may be about or less than 1 mm thick and may be formed of quartz. The bio-medium is a hydrogel.
In describing one or more of these embodiments, the present disclosure may offer several advantages over prior art devices. In the discussion of the advantages or benefits that follows it should be noted that these benefits and/or results may be present is some embodiments, but are not required in every embodiment. Further, it is understood that different embodiments disclosed herein offer different features and advantages, and that various changes, substitutions and alterations may be made without departing from the spirit and scope of the present disclosure.
This application is a continuation of U.S. patent application Ser. No. 15/603,128, filed May 23, 2017, and entitled “Method to Produce Chemical Patter In Micro-Fluidic Structure” which is a divisional of U.S. patent application Ser. No. 15/167,764, filed on May 27, 2016, now U.S. Pat. No. 9,656,260, issued on May 23, 2017, and entitled “Method to Produce Chemical Patter In Micro-Fluidic Structure” which is a divisional application of U.S. patent application Ser. No. 14/040,303 filed on Sep. 27, 2013, now U.S. Pat. No. 9,352,315 issued on May 31, 2016, entitled “A Method to Produce Chemical Pattern in Micro-Fluidic Structure,” each of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3950649 | Yonekubo | Apr 1976 | A |
4222743 | Wang | Sep 1980 | A |
4563062 | Kanatani | Jan 1986 | A |
5184021 | Smith | Feb 1993 | A |
5324633 | Fodor et al. | Jun 1994 | A |
5422712 | Ogino | Jun 1995 | A |
5451683 | Barrett et al. | Sep 1995 | A |
5482867 | Barrett et al. | Jan 1996 | A |
5491074 | Aldwin et al. | Feb 1996 | A |
5599675 | Brenner | Feb 1997 | A |
5624711 | Sundberg et al. | Apr 1997 | A |
5646411 | Kain et al. | Jul 1997 | A |
5744305 | Fodor et al. | Apr 1998 | A |
5750341 | Macevicz | May 1998 | A |
5795716 | Chee | Aug 1998 | A |
5831070 | Pease et al. | Nov 1998 | A |
5856101 | Hubbell et al. | Jan 1999 | A |
5858659 | Sapolsky et al. | Jan 1999 | A |
5874219 | Rava et al. | Feb 1999 | A |
5945334 | Besemer et al. | Aug 1999 | A |
5968740 | Fodor et al. | Oct 1999 | A |
5974164 | Chee | Oct 1999 | A |
5981185 | Matson et al. | Nov 1999 | A |
5981956 | Stern | Nov 1999 | A |
6022963 | McGall et al. | Feb 2000 | A |
6025601 | Trulson et al. | Feb 2000 | A |
6033860 | Lockhart et al. | Mar 2000 | A |
6083697 | Beecher et al. | Jul 2000 | A |
6090555 | Fiekowsky et al. | Jul 2000 | A |
6136269 | Winkler et al. | Oct 2000 | A |
6291183 | Pirrung et al. | Sep 2001 | B1 |
6309831 | Goldberg et al. | Oct 2001 | B1 |
6321791 | Chow | Nov 2001 | B1 |
6327410 | Walt et al. | Dec 2001 | B1 |
6355431 | Chee et al. | Mar 2002 | B1 |
6416949 | Dower et al. | Jul 2002 | B1 |
6428752 | Montagu | Aug 2002 | B1 |
6440748 | Katerkamp et al. | Aug 2002 | B1 |
6482591 | Lockhart et al. | Nov 2002 | B2 |
6509085 | Kennedy | Jan 2003 | B1 |
6569382 | Edman et al. | May 2003 | B1 |
6582660 | Heller et al. | Jun 2003 | B1 |
6644944 | Karp | Nov 2003 | B2 |
6652808 | Heller et al. | Nov 2003 | B1 |
6770441 | Dickinson et al. | Aug 2004 | B2 |
6776094 | Whitesides et al. | Aug 2004 | B1 |
6844184 | Kim et al. | Jan 2005 | B2 |
6919211 | Fodor et al. | Jul 2005 | B1 |
6967074 | Duffy et al. | Nov 2005 | B2 |
7030383 | Babayoff et al. | Apr 2006 | B2 |
7033819 | Kim et al. | Apr 2006 | B2 |
7057026 | Barnes et al. | Jun 2006 | B2 |
7067306 | Singhvi et al. | Jun 2006 | B2 |
7109458 | Fairley et al. | Sep 2006 | B2 |
7115400 | Adessi et al. | Oct 2006 | B1 |
7244559 | Rothberg et al. | Jul 2007 | B2 |
7329860 | Feng et al. | Feb 2008 | B2 |
7344627 | Broadley et al. | Mar 2008 | B2 |
7351376 | Quake et al. | Apr 2008 | B1 |
7445027 | Flachsbart et al. | Nov 2008 | B2 |
7473453 | Fisher | Jan 2009 | B2 |
8039817 | Feng et al. | Oct 2011 | B2 |
8071962 | Feng et al. | Dec 2011 | B1 |
8143599 | Feng et al. | Mar 2012 | B2 |
8242463 | Feng et al. | Aug 2012 | B2 |
8278630 | Feng et al. | Oct 2012 | B1 |
8313906 | Cao et al. | Nov 2012 | B2 |
8357530 | Matsunaga et al. | Jan 2013 | B2 |
8372577 | Tanaka et al. | Feb 2013 | B2 |
8398936 | Horiuchi et al. | Mar 2013 | B2 |
8445194 | Drmanac et al. | May 2013 | B2 |
8507180 | Washio et al. | Aug 2013 | B2 |
8546772 | Feng et al. | Oct 2013 | B2 |
8586947 | Feng et al. | Nov 2013 | B1 |
8637242 | Washio et al. | Jan 2014 | B2 |
8698102 | Feng et al. | Apr 2014 | B2 |
8702948 | Ronaghi et al. | Apr 2014 | B2 |
8778849 | Bowen et al. | Jul 2014 | B2 |
8820883 | Wang et al. | Sep 2014 | B2 |
8900529 | Shaikh et al. | Dec 2014 | B2 |
8951716 | Liu et al. | Feb 2015 | B2 |
8951781 | Reed et al. | Feb 2015 | B2 |
9039997 | Cohen et al. | May 2015 | B2 |
9068220 | Feng et al. | Jun 2015 | B2 |
9073962 | Fracchia et al. | Jul 2015 | B2 |
9114396 | Tsai et al. | Aug 2015 | B2 |
9352315 | Tsai et al. | May 2016 | B2 |
9365898 | Feng et al. | Jun 2016 | B2 |
9458485 | Schultz et al. | Oct 2016 | B2 |
9512422 | Barnard et al. | Dec 2016 | B2 |
9515159 | Bischopink et al. | Dec 2016 | B2 |
9656260 | Tsai et al. | May 2017 | B2 |
9764505 | Guenther et al. | Sep 2017 | B2 |
9809852 | Esfandyarpour et al. | Nov 2017 | B2 |
10486153 | Tsai et al. | Nov 2019 | B2 |
20020030811 | Schindler | Mar 2002 | A1 |
20020094572 | Singhvi et al. | Jul 2002 | A1 |
20020102578 | Dickinson et al. | Aug 2002 | A1 |
20020139936 | Dumas | Oct 2002 | A1 |
20020143111 | Halverson et al. | Oct 2002 | A1 |
20030008310 | Williams et al. | Jan 2003 | A1 |
20030011772 | Abe et al. | Jan 2003 | A1 |
20030032048 | Kim et al. | Feb 2003 | A1 |
20030108900 | Oliphant et al. | Jun 2003 | A1 |
20030152490 | Trulson et al. | Aug 2003 | A1 |
20030156992 | Anderson et al. | Aug 2003 | A1 |
20030215821 | Gunderson et al. | Nov 2003 | A1 |
20040096831 | Hughes | May 2004 | A1 |
20040121066 | Anderson et al. | Jun 2004 | A1 |
20040175710 | Haushalter | Sep 2004 | A1 |
20040185483 | Stuelpnagel et al. | Sep 2004 | A1 |
20040248287 | Hu et al. | Dec 2004 | A1 |
20050057798 | Osborne et al. | Mar 2005 | A1 |
20050064432 | Huang et al. | Mar 2005 | A1 |
20050100900 | Kawashima et al. | May 2005 | A1 |
20050181394 | Steemers et al. | Aug 2005 | A1 |
20050191698 | Chh et al. | Sep 2005 | A1 |
20050205422 | Moser et al. | Sep 2005 | A1 |
20050221271 | Murphy et al. | Oct 2005 | A1 |
20050236361 | Ufer et al. | Oct 2005 | A1 |
20050272142 | Horita | Dec 2005 | A1 |
20060065528 | Lopez et al. | Mar 2006 | A1 |
20060188901 | Barnes et al. | Aug 2006 | A1 |
20060240439 | Smith et al. | Oct 2006 | A1 |
20060253035 | Stern | Nov 2006 | A1 |
20060281109 | Barr Ost et al. | Dec 2006 | A1 |
20070000866 | Ryan et al. | Jan 2007 | A1 |
20070085334 | Watanabe et al. | Apr 2007 | A1 |
20070114362 | Feng et al. | May 2007 | A1 |
20070166705 | Milton et al. | Jul 2007 | A1 |
20080202694 | Serbicki et al. | Aug 2008 | A1 |
20080261288 | Gonda et al. | Oct 2008 | A1 |
20080262747 | Kain et al. | Oct 2008 | A1 |
20080274905 | Greene | Nov 2008 | A1 |
20080297911 | Christenson et al. | Dec 2008 | A1 |
20090068759 | Arenas et al. | Dec 2009 | A1 |
20090298191 | Whitesides et al. | Dec 2009 | A1 |
20090309049 | Van Dijk et al. | Dec 2009 | A1 |
20100111768 | Bnerjee et al. | May 2010 | A1 |
20100210008 | Strand et al. | Aug 2010 | A1 |
20100233696 | Joseph et al. | Sep 2010 | A1 |
20100327184 | Hayashi | Dec 2010 | A1 |
20110091864 | Karlsson et al. | Apr 2011 | A1 |
20110195260 | Lee et al. | Aug 2011 | A1 |
20120004140 | Staker | Jan 2012 | A1 |
20120182609 | Borenstein et al. | Jul 2012 | A1 |
20120184046 | Atkin | Jul 2012 | A1 |
20120319180 | Chuang et al. | Dec 2012 | A1 |
20140155297 | Heinz | Jun 2014 | A1 |
20140243224 | Barnard et al. | Aug 2014 | A1 |
20140256030 | Shen et al. | Sep 2014 | A1 |
20140272719 | Liu et al. | Sep 2014 | A1 |
20140349870 | Aizenberg et al. | Nov 2014 | A1 |
20140371091 | Wiktor et al. | Dec 2014 | A1 |
20150087007 | Meldrum et al. | Mar 2015 | A1 |
20150375226 | Yoo | Dec 2015 | A1 |
20160023208 | Fisher et al. | Jan 2016 | A1 |
20160318016 | Hou et al. | Nov 2016 | A1 |
20170326548 | Tsai et al. | May 2017 | A1 |
20170151584 | Wiesner et al. | Jun 2017 | A1 |
20200009556 | Zimmerley et al. | Jan 2020 | A1 |
20200347273 | Stockholm et al. | Nov 2020 | A1 |
Number | Date | Country |
---|---|---|
101498656 | Aug 2009 | CN |
101598717 | Dec 2009 | CN |
101807705 | Aug 2010 | CN |
10014204 | Oct 2001 | DE |
2007-183258 | Jul 2007 | JP |
WO-9844151 | Oct 1998 | WO |
WO-0018957 | Apr 2000 | WO |
WO-0063437 | Oct 2000 | WO |
WO-2005065814 | Jul 2005 | WO |
WO-2006064199 | Jun 2006 | WO |
WO-2007010251 | Jan 2007 | WO |
WO-2007123744 | Nov 2007 | WO |
WO-2010009543 | Jan 2010 | WO |
WO-2010099350 | Sep 2010 | WO |
Entry |
---|
Office Action dated Jun. 25, 2020 in U.S. Appl. No. 16/000,720. |
Notice of Allowance dated Dec. 31, 2020 in U.S. Appl. No. 16/000,720. |
Office Action dated Apr. 18, 2019 in U.S. Appl. No. 15/603,128 (now U.S. Pat. No. 10,486,153). |
Matsunaga et al., “High-Efficiency Single-Cell Entrapment and Fluorescence in Situ Hybridization Analysis Using a Poly(dimethylsiloxane) Microfluidic Device Integrated with a Black Poly(ethylene terephthalate) Micromesh,” Analytical Chemistry, vol. 80, No. 13, (Jun. 7, 2008) pp. 5139-5145 (Year: 2008). |
Office Action dated May 13, 2021, in U.S. Appl. No. 16/457,667 (2020-009556). |
U.S. Appl. No. 15/926,322, filed Mar. 20, 2018, Feng et al. |
U.S. Appl. No. 16/000,720, filed Jun. 5, 2018, Feng et al. |
U.S. Appl. No. 16/457,667, filed Jun. 28, 2019, Zimmerley et al. |
AppliChem GmbH (Darmstadt, Germany), “Contaminations by Nucleic Acids, Problems and Practical Solutions,” Nucleic acid decontamination, Brochure, 2008, 1-64. |
Chinese Patent Application No. 20098116690.4, Office Action dated Feb. 28, 2013, 9 pages. |
Chou et al., “Integrated Elastomer Fluidic Lab-on-a-chip-Surface Patterning and DNA Diagnostics,” Proceedings of the Solid State Actuator and Sensor Workshop, Hilton Head, South Carolina, 2000, 4 pages. |
Dworkin, M. et al., “Life at High Temperatures,” Chapter 1.7, The Prokaryotes: A Handbook on the Biology of Bacteria, Third Edition, vol. 2: Ecophysiology and Biochemistry, 2006, 183-188. |
Eddings, M. et al., “Determining the optimal PDMS-PDMS bonding technique for microfluidic devices,” J. Micromech. Microeng., 18, 067001, 2008, 4 pages. |
EP Application No. 09743421.1, Communication Pursuant to Article 94(3) EPC, dated Oct. 2, 2015, 4 pages. |
Fiorini, G. et al., “Disposable microfluidic devices: fabrication, function, and application,” BioTechniques, vol. 38 (3), Mar. 2005, 429-446. |
Flachsbart, B. et al., “Design and fabrication of a multilayered polymer microfluidic chip with nanofluidic interconnects via adhesive contact printing,” Lab on a Chip, 6, 2006, 667-674. |
Gerday, C. et al., “Extremophiles,” Encyclopedia of life support systems (EOLSS), 2009, 194-203. |
Grogan, D., “Hyperthermophiles and the problem of DNA instability,” Molecular Microbiology, vol. 28 (6), 1998, 1043-1049. |
Grover, W. et al., “Monolithic membrane valves and diaphragm pumps for practical large-scale integration into glass microfluidic devices,” Sensors and Actuators B, 89, 2003, 315-323. |
Karni, M. et al., “Thermal Degradation of DNA,” DNA and Cell Biology, vol. 32 (6), 2013, 1-4. |
Kim, J. et al., “Rapid prototyping of microfluidic systems using a PDMS/polymer tape composite,” Lab on a Chip, vol. 9, 2009, 1290-1293. |
Koch Lab: Protocols/Flow cell, https://openwetware.org/mediawiki/index.php?title=Koch_Lab:Protocols/Flow_cell&oldid=397835, accessed on Oct. 25, 2017. |
Lee, H.-J. et al., “SPR Imaging Measurements of 1-D and 2-D DNA Microarrays Created from Microfluidic Channels on Gold Thin Films,” Anal. Chem. 2001, 73, 2001, 5525-5531. |
Lindahl, T. et al., “Rate of Depurination of Native Deoxyribonucleic Acid,” Biochemistry, vol. 11 (19), 1972, 3610-3618. |
Lindahl, I., “Instability and Decay of the Primary Structure of DNA,” Nature, vol. 362, Apr. 22, 1993, 709-715. |
Long, Z. et al., “Integrated multilayer microfluidic device with a nanoporous membrane interconnect for online coupling of solid-phase extraction to microchip electrophoresis,” Lab Chip, 7, 2007, 1819-1824. |
Marguet, E. et al., “DNA stability at temperatures typical for hyperthermophiles,” Nucleic acids research, vol. 22 (9), 1994, 1681-1686. |
Meyers, R., “Denaturation of DNA,” Molecular Biology and Biotechnology: A Comprehensive Desk Reference, 1995, 206-207. |
Ong, S.E. et al., “Fundamental principles and applications of microfluidic systems,” Frontiers in Bioscience, vol. 13, Jan. 1, 2008, 2757-2773. |
Shendure, et al., “Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome,” Science, vol. 309, Sep. 9, 2005, 1728-1732. |
Stroock, A. et al., “Components for integrated poly(dimethylsiloxane) microfluidic systems,” Electrophoresis, 23, 2002, 3461-3473. |
Sun Wei, “Scanning Probe Microscopy Imaging of Biological Origin and FDTD Simulation of Optical Tweezers,” Doctor's Degree Theses from Dalian University of Technology, 2006, 60-67. |
Yuen, P.K. et al., “Microfluidic devices for fluidic circulation and mixing improve hybridization signal intensity on DNA arrays,” Lab Chip, 3, 2003, 46-50. |
Zhang, M. et al., “A simple method for fabricating multi-layer PDMS structures for 3D microfluidic chips,” Lab Chip, 10, 2010, 1199-1203. |
Final Office Action dated Sep. 7, 2021 in U.S. Appl. No. 16/457,667 (US 2020-009556). |
U.S. Office Action dated Dec. 24, 2021 in U.S. Appl. No. 16/457,667 (US 2020-0009556). |
Number | Date | Country | |
---|---|---|---|
20200070153 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15167764 | May 2016 | US |
Child | 15603128 | US | |
Parent | 14040303 | Sep 2013 | US |
Child | 15167764 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15603128 | May 2017 | US |
Child | 16677501 | US |